[1] Poon AH, Eidelman DH, Martin JG, et al.Pathogenesis of severe asthma[J].Clin Exp Allergy,2012, 42(5):625-637. [2] Evasovic JM, Singer CA.Regulation of IL-17A and implications for TGF-β1 comodulation of airway smooth muscle remodeling in severe asthma[J].Am J Physiol Lung Cell Mol Physiol,2019,316(5):L843-L868. [3] Zhang L, Lasmar LB, Castro-Rodriguez JA.The impact of asthma and its treatment on growth: an evidence-based review[J].J Pediatr (Rio J),2019,95 (Suppl 1):10-22. [4] 侯伟,刘海燕,杨旭东,等.氧化苦参碱对哮喘小鼠肺组织中TGF-β1及AngII表达的影响[J].中国儿童保健杂志,2010,18(2):135-143. [5] Casaro M, Souza VR, Oliveira FA, et al.OVA-induced allergic airway inflammation mouse model[J].Methods Mol Biol,2019,1916:297-301. [6] Muehling LM, Lawrence MG, Woodfolk JA.Pathogenic CD4+ T cells in patients with asthma[J].J Allergy Clin Immunol,2017,140(6):1523-1540. [7] Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al.Macrophage plasticity, polarization, and function in health and disease[J].J Cell Physiol,2018,233(9):6425-6440. [8] 赖欣,王丽丽,龚娅琼,等.CpG ODN在免疫佐剂中的研究新进展[J].药物生物技术,2019,26(1):73-77. [9] Givens BE, Geary SM, Salem AK.Nanoparticle-based CpG-oligonucleotide therapy for treating allergic asthma[J].Immunotherapy,2018,10(7):595-604. [10] Kim DH,Sohn JH,Park HJ,et al.CpG Oligodeoxynucleotide inhibits cockroach-induced asthma via induction of IFN-γ + Th1 cells or Foxp3 + regulatory T cells in the lung[J].Allergy Asthma Immunol Res,2016,8(3):264-275. [11] Wachstein J, Tischer S, Figueiredo C, et al.Hsp70 enhances immunosuppressive function of CD4(+)CD25(+) FoxP3(+) Tregulatory cells and cytotoxicity in CD4(+)CD25(-) T cells [J].PloS One,2012,7(12):51747-51777. [12] 李燕,谢敏,史小玲,等.HSP70/CD80 DNA疫苗通过调节Th1/Th2/Treg/Th17细胞对急性哮喘的抑制作用[J].山东大学学报:医学版,2014,10(52):20-24. [13] Yao X, Sun Y, Wang W, et al.Interleukin (IL)-25: Pleiotropic roles inasthma[J].Respirology.2016,21(4):638-647. [14] Johansson K, McSorley HJ.Interleukin-33 in the developing lung-Roles in asthma and infection[J].Pediatr Allergy Immunol,2019,30(5):503-510. [15] Mitchell PD, O′Byrne PM.Epithelial-derived cytokines in asthma[J].Chest,2017,151(6):1338-1344. [16] 李征,刘晔,李春阳.减毒活疫苗的应用及其研究进展[J].中国生物制品学杂志,2018,31(2):205-209. [17] Francis MJ.Recent advances in vaccine technologies[J].Vet Clin North Am Small Anim Pract,2018,48(2):231-241. [18] 喻吉,林彩,李海波,等.人用疫苗佐剂及其免疫学机制研究现状[J].免疫学杂志,2018,34(9):811-817. [19] Shi S, Zhu H, Xia X, et al.Vaccine adjuvants: understanding the structure and mechanism of adjuvanticity[J].Vaccine,2019,37(24):3167-3178. [20] Reed SG, Orr MT, Fox CB.Key roles of adjuvants in modern vaccines[J] .Nat Med, 2013, 19(12): 1597-1608. [21] Salem AK.A promising CpG adjuvant-loaded nanoparticle-based vaccine for treatment of dust mite allergies[J].Immuno-therapy,2014,6(11):1161-1163. |